Opaleye Management Inc. - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 23 filers reported holding AVENUE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$10,664,000
-4.3%
984,692
-4.9%
2.09%
-7.3%
Q2 2020$11,147,000
+20.5%
1,035,0000.0%2.25%
-8.2%
Q1 2020$9,253,000
-6.9%
1,035,0000.0%2.45%
+25.7%
Q4 2019$9,936,000
+75.0%
1,035,000
+8.7%
1.95%
-5.0%
Q3 2019$5,677,000
-3.1%
952,600
+2.4%
2.05%
+14.9%
Q2 2019$5,859,000
+54.2%
930,000
+16.2%
1.79%
+69.8%
Q1 2019$3,800,000
+41.9%
800,000
+61.3%
1.05%
+5.3%
Q4 2018$2,678,000496,0001.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
B. Riley Wealth Advisors, Inc. 170,487$1,035,0000.04%
Trexquant Investment LP 13,874$84,0000.01%
Nantahala Capital Management 30,211$183,0000.01%
Berman Capital Advisors, LLC 610$3,0000.00%
Squarepoint Ops LLC 11,668$71,0000.00%
BNP PARIBAS FINANCIAL MARKETS 802$4,868,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,884$24,0000.00%
BANK OF AMERICA CORP /DE/ 10,244$63,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 198$2,0000.00%
WELLS FARGO & COMPANY/MN 3,687$22,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders